Burning Rock Biotech founder and CEO purchases company ADSs

Burning Rock Biotech’s (BNR) founder, chairman of the board and CEO, Yusheng Han, has purchased 31,487 of the company’s ADSs for $546,603.90 from the open market, in compliance with the applicable rules and regulations and the Company’s insider trading policy. Combined with 41,246 ADSs purchased in the last post-earnings trading window, Han has purchased an aggregate of 72,733 of the company’s ADSs for $1,358,325.18 across two consecutive post-earnings trading windows. The timing and conditions of Mr. Han’s purchase will be subject to various factors, including the requirements under Rule 10b-18 and Rule 10b5-1 of the Securities Exchange Act of 1934, as well as the company’s insider trading policy.